Vice President, M&A and Strategy at Danaher Corporation

Marlborough, Massachusetts, United States

Danaher Corporation Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Life Sciences, DiagnosticsIndustries

Requirements

  • Bachelor’s degree in Life Sciences, Economics, Finance, or related field as well as an MBA or Masters Degree
  • 10+ years in M&A, corporate development, corporate strategy, investment banking, or private equity, with at least 5 years in life sciences or biotech
  • 2-4 years in a top-tier consulting firm or equivalent experience focused on market analysis and/or growth/strategy commercial project; or an investment firm including PE or VC, or equivalent experience
  • Experience leading M&A diligence projects and experience in strategic planning and market analysis at a senior level
  • Ability to lead market research projects executing VOC, use multiple other data sources to synthesize insights into specific and actionable findings
  • Deep financial modeling, valuation, and due diligence expertise. Prior experience building ROIC models
  • Strong strategic thinking and ability to synthesize complex market data into actionable plans
  • Exceptional communication and presentation skills for executive and board-level audiences
  • Ability to thrive in a matrixed organization and influence senior stakeholders

Responsibilities

  • Own the full M&A lifecycle: target identification, valuation modeling, due diligence, negotiation, execution, and integration planning while collaborating closely with Cytiva leadership and Danaher Corporate Development to ensure seamless execution and integration
  • Cultivate relationships with potential acquisition targets, investment banks, and external advisors and build and maintain a robust acquisition pipeline aligned with BTG’s strategic priorities, including mid-, near-, and long-term targets
  • Lead or co-lead the annual strategic planning process for BTG, including market analysis, competitive benchmarking, and scenario planning
  • Develop thought leadership on emerging and established industry trends to inform strategic priorities and translate strategic insights into actionable growth initiatives, including organic and inorganic opportunities
  • Prepare board-level presentations and executive updates on strategic direction and M&A progress
  • Partner with Finance, Legal, R&D, Commercial, and Operations teams to ensure alignment and execution of strategic initiatives
  • Drive post-acquisition integration planning and performance tracking

Skills

M&A
Strategic Planning
Valuation Modeling
Due Diligence
Negotiation
Deal Execution
Integration Planning
Financial Modeling
Partnerships
Life Sciences

Danaher Corporation

Water quality, diagnostics, and identification solutions

About Danaher Corporation

Danaher Corporation operates in key markets such as water quality, product identification, and diagnostics. The company provides precision instruments and advanced purification technologies for analyzing and managing water, ensuring its safety in various environments. In product identification, Danaher specializes in laser marking, coding, and packaging solutions that help maintain product freshness and accurate labeling throughout the supply chain. In the diagnostics sector, Danaher offers tools and software that enhance diagnostic confidence, enabling healthcare providers to deliver effective care. What sets Danaher apart from competitors is its unique Danaher Business System, which focuses on continuous improvement and empowers employees to drive change. The company's goal is to consistently deliver high-performance products and solutions while maintaining leadership in its markets.

Washington, District of ColumbiaHeadquarters
1969Year Founded
IPOCompany Stage
Industrial & Manufacturing, Healthcare, Consumer GoodsIndustries
10,001+Employees

Risks

Increased competition from Roche and Abbott in AI-driven diagnostics.
Potential regulatory challenges in the EU for water quality sector.
Supply chain vulnerabilities affecting precision instruments sourcing.

Differentiation

Danaher's Danaher Business System drives continuous improvement and superior financial performance.
The acquisition of Cytiva enhances Danaher's capabilities in the biopharmaceutical sector.
Danaher's advanced purification technologies meet increasing demands for sustainable water management.

Upsides

Danaher's investment in AI-driven healthcare solutions boosts its diagnostics capabilities.
Cytiva acquisition expands Danaher's market share in the biopharmaceutical sector.
Point-of-care testing demand drives growth for Danaher's diagnostic tools and software.

Land your dream remote job 3x faster with AI